Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities as an adjunct to reduced-calorie diet and increased physical activity
This dual action has positioned Melanotan II as a unique option for individuals seeking a deeper, more even tan and enhanced libido support
It is important to contextualise these results carefully: Phase 2 trials involve relatively small, controlled populations and are not sufficient on their own to establish a medicine's full safety profile or its suitability for broad clinical use
The drug has been approved globally for the management of type 2 diabetes mellitus in adult patients in the U.S
